A226330 Share Price Performance
₩0
-6280.00 (-100.00%)
Price ₩0
Share Pricen/a
Does SyntekaBio (KOSDAQ:226330) Have A Healthy Balance Sheet?
Nov 30
SyntekaBio, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A226330 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
SyntekaBio, Inc. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -726.74
- 99.68%
- -988.55%
- 106.1%
About A226330
- Founded
- 2009
- Employees
- 52
- CEO
- WebsiteView website
SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea. It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology. The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology. The company was founded in 2009 and is headquartered in Daejeon, South Korea.
